Abstract
Proteases play an important role in various aspects of angiogenesis. First, pericellular proteolysis facilitates matrix degradation as well as migration and invasion of capillary sprouts into its surrounding matrix. (Membrane-type) matrix metalloproteases [(MT-)MMPs], ADAM(TS) metalloproteases, serine proteases, their inhibitors, and occasionally cysteine proteases are important players in pericellular proteolysis. The specific location and short exposure of protease activity can be explained by a tread-milling model with internalization of protease–receptor complexes as was proposed for MT1-MMP/MMP2 and urokinase/urokinase receptor complexes. Second, proteolytic events play a role in regulating VEGF-induced sprouting, such as proteasomal degradation of hypoxia inducible factors (HIFs), Notch-mediated cell signaling, and turnover of VEGF receptors. Third, proteases can activate and modify growth factors and receptors and thus generate split products with new biological functions and contribute to cell recruitment. Proteases likely also contribute to formation of anastomoses, which is required to restore circulation. Finally, new biological functions are also acquired by generation of split products from and modifications of matrix proteins. They include angiogenesis-inhibiting matrikines, and modified fibrin forms with altered angiogenic properties, which may bear perspective for tissue engineering applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carmeliet P, Collen D (1998) Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res 91(6):255–285
Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161–174
van Hinsbergh VWM, Engelse MA, Quax PH (2006) Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26(4):716–728
Verloop RE, Koolwijk P, van Zonneveld AJ, van Hinsbergh VW (2009) Proteases and receptors in the recruitment of endothelial progenitor cells in neovascularization. Eur Cytokine Netw 20(4):207–219
van Hinsbergh VWM, Koolwijk P (2008) Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 78(2):203–212
Davis GE, Stratman AN, Sacharidou A, Koh W (2011) Molecular basis for endothelial lumen formation and tubulogenesis during vasculogenesis and angiogenic sprouting. Int Rev Cell Mol Biol 288:101–165
Lopez-Otin C, Bond JS (2008) Proteases: multifunctional enzymes in life and disease. J Biol Chem 283(45):30433–30437
Blasi F, Carmeliet P (2002) uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3(12):932–943
Andreasen PA, Egelund R, Petersen HH (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57(1):25–40
Roy R, Zhang B, Moses MA (2006) Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res 312(5):608–622
Lijnen HR (2001) Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 86(1):324–333
Van De Craen B, Scroyen I, Vranckx C, Compernolle G, Lijnen HR, Declerck PJ et al (2012) Maximal PAI-1 inhibition in vivo requires neutralizing antibodies that recognize and inhibit glycosylated PAI-1. Thromb Res 129(4):e126–e133
Syrovets T, Simmet T (2004) Novel aspects and new roles for the serine protease plasmin. Cell Mol Life Sci 61(7–8):873–885
Matsuno H (2006) Alpha2-antiplasmin on cardiovascular diseases. Curr Pharm Des 12(7):841–847
Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52–67
Newby AC (2005) Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85(1):1–31
Spinale FG, Janicki JS, Zile MR (2013) Membrane-associated matrix proteolysis and heart failure. Circ Res 112(1):195–208
Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92(8):827–839
Nagase H, Woessner JFJ (1999) Matrix metalloproteinases. J Biol Chem 274(31):21491–21494
Butler GS, Overall CM (2009) Updated biological roles for matrix metalloproteinases and new “intracellular” substrates revealed by degradomics. Biochemistry 48(46):10830–10845
Rodriguez D, Morrison CJ, Overall CM (2010) Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta 1803(1):39–54
Handsley MM, Edwards DR (2005) Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 115(6):849–860
Bauvois B (2012) New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta 1825(1):29–36
Williams KC, Coppolino MG (2011) Phosphorylation of membrane type 1-matrix metalloproteinase (MT1-MMP) and its vesicle-associated membrane protein 7 (VAMP7)-dependent trafficking facilitate cell invasion and migration. J Biol Chem 286(50):43405–43416
Galvez BG, Matias-Roman S, Yanez-Mo M, Vicente-Manzanares M, Sanchez-Madrid F, Arroyo AG (2004) Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol Biol Cell 15(2):678–687
Brew K, Nagase H (2010) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803(1):55–71
Vagima Y, Avigdor A, Goichberg P, Shivtiel S, Tesio M, Kalinkovich A et al (2009) MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. J Clin Invest 119(3):492–503
Mascall KS, Small GR, Gibson G, Nixon GF (2012) Sphingosine-1-phosphate-induced release of TIMP-2 from vascular smooth muscle cells inhibits angiogenesis. J Cell Sci 125(Pt 9):2267–2275
Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R et al (2003) TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 114(2):171–180
Kumar S, Rao N, Ruowen G (2012) Emerging roles of ADAMTSs in angiogenesis and cancer. Cancers 4(4):1252–1299
Kostoulas G, Lang A, Nagase H, Baici A (1999) Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases. FEBS Lett 455(3):286–290
Urbich C, Heeschen C, Aicher A, Sasaki K, Bruhl T, Farhadi MR et al (2005) Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med 11(2):206–213
Mohamed MM, Sloane BF (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6(10):764–775
Kobayashi H, Moniwa N, Sugimura M, Shinohara H, Ohi H, Terao T (1993) Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes. Biochim Biophys Acta 1178(1):55–62
Sakamoto T, Seiki M (2010) A membrane protease regulates energy production in macrophages by activating hypoxia-inducible factor-1 via a non-proteolytic mechanism. J Biol Chem 285(39):29951–29964
Nishida C, Kusubata K, Tashiro Y, Gritli I, Sato A, Ohki-Koizumi M et al (2012) MT1-MMP plays a critical role in hematopoiesis by regulating HIF-mediated chemokine/cytokine gene transcription within niche cells. Blood 119(23):5405–5416
Chen TT, Luque A, Lee S, Anderson SM, Segura T, Iruela-Arispe ML (2010) Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells. J Cell Biol 188(4):595–609
Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169(4):681–691
Nakayama M, Nakayama A, van Lessen M, Yamamoto H, Hoffmann S, Drexler HCA et al (2013) Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat Cell Biol 15(3):249–260
Jakobsson L, Franco CA, Bentley K, Collins RT, Ponsioen B, Aspalter IM et al (2010) Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol 12(10):943–953
Potente M, Gerhardt H, Carmeliet P (2011) Basic and therapeutic aspects of angiogenesis. Cell 146(6):873–887
Funahashi Y, Shawber CJ, Sharma A, Kanamaru E, Choi YK, Kitajewski J (2011) Notch modulates VEGF action in endothelial cells by inducing matrix metalloprotease activity. Vasc Cell 3(1):2
Kamei M, Saunders WB, Bayless KJ, Dye L, Davis GE, Weinstein BM (2006) Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 442(7101):453–456
Strilic B, Kucera T, Eglinger J, Hughes MR, McNagny KM, Tsukita S et al (2009) The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell 17(4):505–515
Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H et al (2002) CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J 21(15):3949–3959
Tjwa M, Sidenius N, Moura R, Jansen S, Theunissen K, Andolfo A et al (2009) Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells. J Clin Invest 119(4):1008–1018
Uekita T, Itoh Y, Yana I, Ohno H, Seiki M (2001) Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol 155(7):1345–1356
Gonzalo P, Guadamillas MC, Hernandez-Riquer MV, Pollan A, Grande-Garcia A, Bartolome RA et al (2010) MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. Dev Cell 18(1):77–89
Sacharidou A, Koh W, Stratman AN, Mayo AM, Fisher KE, Davis GE (2010) Endothelial lumen signaling complexes control 3D matrix-specific tubulogenesis through interdependent Cdc42- and MT1-MMP-mediated events. Blood 115(25):5259–5269
Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, Prykhozhij S et al (2010) Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116(5):829–840
Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y (2002) Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 277(39):36288–36295
McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I et al (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276(47):43503–43508
Mourad JJ, Des Guetz G, Debbabi H, Levy BI (2008) Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation. Ann Oncol 19(5):927–934
van der Veldt AAM, de Boer MP, Boven E, Eringa EC, van den Eertwegh AJM, van Hinsbergh VW et al (2010) Reduction in skin microvascular density and changes in vessel morphology in patients treated with sunitinib. Anticancer Drugs 21(4):439–446
Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P et al (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6(3):315–325
Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, Thorpe PE et al (2002) Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 21(46):7011–7026
Arroyo AG, Iruela-Arispe ML (2010) Extracellular matrix, inflammation, and the angiogenic response. Cardiovasc Res 86(2):226–235
Barczyk M, Carracedo S, Gullberg D (2010) Integrins. Cell Tissue Res 339(1):269–280
Laurens N, Koolwijk P, de Maat MP (2006) Fibrin structure and wound healing. J Thromb Haemost 4(5):932–939
Holm B, Nilsen DW, Kierulf P, Godal HC (1985) Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thromb Res 37(1):165–176
Henschen-Edman AH (2001) Fibrinogen non-inherited heterogeneity and its relationship to function in health and disease. Ann N Y Acad Sci 936:580–593
de Maat MP, Verschuur M (2005) Fibrinogen heterogeneity: inherited and noninherited. Curr Opin Hematol 12(5):377–383
Nakashima A, Sasaki S, Miyazaki K, Miyata T, Iwanaga S (1992) Human fibrinogen heterogeneity: the COOH-terminal residues of defective A alpha chains of fibrinogen II. Blood Coagul Fibrinolysis 3(4):361–370
Manten GTR, Sikkema JM, Franx A, Hameeteman TM, Visser GHA, de Groot PG et al (2003) Increased high molecular weight fibrinogen in pre-eclampsia. Thromb Res 111(3):143–147
Danesh J, Lewington S, Thompson SG, Lowe GDO, Collins R, Kostis JB et al (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294(14):1799–1809
Holm B, Godal HC (1984) Quantitation of the three normally-occurring plasma fibrinogens in health and during so-called “acute phase” by SDS electrophoresis of fibrin obtained from EDTA-plasma. Thromb Res 35(3):279–290
Kaijzel EL, Koolwijk P, van Erck MG, van Hinsbergh VWM, de Maat MP (2006) Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo. J Thromb Haemost 4(9):1975–1981
Weijers EM, Van Wijhe MH, Joosten L, Horrevoets AJ, de Maat MP, van Hinsbergh VWM et al (2010) Molecular weight fibrinogen variants alter gene expression and functional characteristics of human endothelial cells. J Thromb Haemost 8(12):2800–2809
Zucker S, Cao J (2009) Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: ready for prime time? Cancer Biol Ther 8(24):2371–2373
Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295(5564):2387–2392
Ulisse S, Baldini E, Sorrenti S, D’Armiento M (2009) The urokinase plasminogen activator system: a target for anti-cancer therapy. Curr Cancer Drug Targets 9(1):32–71
Overall CM, Blobel CP (2007) In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol 8(3):245–257
Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR et al (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109(5):625–637
Segers VFM, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT (2007) Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 116(15):1683–1692
Dai J, Agelan A, Yang A, Zuluaga V, Sexton D, Colman RW et al (2012) Role of plasma kallikrein-kinin system activation in synovial recruitment of endothelial progenitor cells in experimental arthritis. Arthritis Rheum 64(11):3574–3582
Reing JE, Zhang L, Myers-Irvin J, Cordero KE, Freytes DO, Heber-Katz E et al (2009) Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A 15(3):605–614
Iwakura A, Shastry S, Luedemann C, Hamada H, Kawamoto A, Kishore R et al (2006) Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 113(12):1605–1614
Deryugina EI, Quigley JP (2010) Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions. Biochim Biophys Acta 1803(1):103–120
Xiao Q, Zhang F, Lin L, Fang C, Wen G, Tsai TN et al (2013) Functional role of matrix metalloproteinase-8 in stem/progenitor cell migration and their recruitment into atherosclerotic lesions. Circ Res 112(1):35–47
Acknowledgments
This work was supported by grants of The Netherlands Institute for Regenerative Medicine (NIRM, workpackage hypoxia and angiogenesis).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Weijers, E.M., van Hinsbergh, V.W.M. (2013). Multiple Roles of Proteases in Angiogenesis. In: Dulak, J., Józkowicz, A., Łoboda, A. (eds) Angiogenesis and Vascularisation. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1428-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1428-5_4
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1427-8
Online ISBN: 978-3-7091-1428-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)